Kristina M. Haley - Concepedia

Author

Kristina M. Haley

Oregon Health & Science University ORCID

Also Known As

Haley, Kristina M., J. Scanlon, K. Haley, K. M. Haley, K.M. Haley, Kristina Haley, Kristina M Haley, Kristina M. Haley, Robert C Mignacca, Rochester Zent

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Oregon Health & Science University Children's Healthcare of Atlanta Emory University St. Jude Children's Research Hospital Boston Children's Hospital

About

Kristina M. Haley is an author at Oregon Health & Science University specializing in medicine, thrombosis, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	407
2	Health Sciences	2	2	88
3	Public Health	2	2	51
4	Cell Biology	1	1	50
5	Cellular Physiology	1	1	50

Kristina M. Haley

Publications

702

Citations

H-Index

Page 1

	Year	Citations
Thrombopoietin Receptor Agonist Use in Children: Data From the Pediatric ITP Consortium of North America ICON2 Study Cindy Neunert, Jenny M. Despotovic, Kristina M. Haley, Pediatric Blood & Cancer	2016	88
Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids‐DOTT trial): pilot/feasibility phase findings Neil A. Goldenberg, Thomas C. Abshire, Patrick J. Blatchford, Journal of Thrombosis and Haemostasis ThrombosisYoung AdultsVenous ThrombosisCardiovascular DiseasePediatric Hematology	2015	66
Assessment of neonatal platelet adhesion, activation, and aggregation Sandra M. Baker-Groberg, Susan Lattimore, Michael Recht, Journal of Thrombosis and Haemostasis ThrombopoiesisThrombosisNeonatal Platelet AdhesionBlood PlateletHematology	2016	56
The PAK system links Rho GTPase signaling to thrombin-mediated platelet activation Joseph E. Aslan, Sandra M. Baker, Cassandra P. Loren, American Journal of Physiology-Cell Physiology Molecular RegulationImmunologyBlood CellRho GtpaseCytoskeleton	2013	50
Second‐line treatments in children with immune thrombocytopenia: Effect on platelet count and patient‐centered outcomes Rachael F. Grace, Kristin A. Shimano, Rukhmi Bhat, American Journal of Hematology Isolated ThrombocytopeniaImmunologyPharmacotherapyKids Itp ToolImmunotherapy	2019	50
Physician decision making in selection of second‐line treatments in immune thrombocytopenia in children Rachael F. Grace, Jenny M. Despotovic, Carolyn M. Bennett, American Journal of Hematology Patient SelectionChronic ItpThrombosisPrimary CareVenous Thrombosis	2018	42
p21 Activated Kinase Signaling Coordinates Glycoprotein Receptor VI–Mediated Platelet Aggregation, Lamellipodia Formation, and Aggregate Stability Under Shear Joseph E. Aslan, Asako Itakura, Kristina M. Haley, Arteriosclerosis Thrombosis and Vascular Biology	2013	39
The impact of extended half‐life factor concentrates on prophylaxis for severe hemophilia in the United States Lynn Malec, Dunlei Cheng, Char Witmer, American Journal of Hematology	2020	31
Do circulating tumor cells play a role in coagulation and thrombosis? Garth W. Tormoen, Kristina M. Haley, Ross L. Levine, Frontiers in Oncology	2012	29
Impact of diagnosis of von Willebrand disease on patient outcomes: Analysis of medical insurance claims data Robert F. Sidonio, Kristina M. Haley, Dana Fallaize Haemophilia DiagnosisClinical SpecialtiesCase SeriesVon Willebrand DiseaseDiagnostic Delay	2017	29

Page 1